This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. The company is a so-called “neocloud” — a data center firm providing outsourced cloud computing for those looking to build AI. billion valuation in the process.
Biotech- and healthcare-related startups led the way as those companies dominate the list, taking a vast majority of spots. In 2023, it partnered with Digital Realty to develop $7 billion in data centers targeting providers of online content, cloud services and artificial intelligence. went, of course, to another biotech firm.
The new fund is just the latest example of investor excitement about healthcare- and biotech-related uses for AI. Venture funding to AI-related biotech and healthcare startups hit only $4.8 billion was raised by AI-related biotech/healthcare related startups. billion in 2023, a significant decrease from 2022.
Medical and biotech had a strong showing at Y Combinator’s latest demo day , with nearly a dozen companies in the space catching my eye. LiliumX is taking the algorithmic approach to generating potential antibody stuctures that could be effective, as many AI-informed biotech companies have before it. Startups take on big pharma.
Biotech offerings, while more plentiful, are also running well below prior highs. Below, we pick out winners and losers for venture-backed tech and biotech companies, focusing on large- and medium-sized IPOs. The provider of AI and cloud connectivity technology was recently valued around $18 billion. Just a handful of U.S.
Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Image Credits: Stämm Biotech. Image Credits: Stämm Biotech. Cells, oxygen and nutrients can be added at a variety of places.
6 questions investors should ask when evaluating psychedelic biotech companies. 6 questions investors should ask when evaluating psychedelic biotech companies. “Our engineers are excited about this move,” said Pellisé. . Gogoro’s public debut could supercharge EV battery swapping across the globe.
Lambda , $480M, artificial intelligence: Lambda, which offers cloud computing services and hardware for training artificial intelligence software, raised a $480 million Series D co-led by Andra Capital and SGW. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in 2025.
The largest was a $275 million January Series F for Innovaccer , a San Francisco startup that makes an AI-enabled cloud tracking platform for healthcare providers. We might even see a pickup as more health and biotech startups incorporate AI as a core focus area, given the technologys rapid advancement and increasing sophistication.
The company is a so-called “neocloud” — a data center firm providing outsourced cloud computing for those looking to build AI. Seaport Therapeutics , $225M, biotech: Seaport Therapeutics isn’t new to this list. The biotech company focuses on medicines for depression, anxiety and other neuropsychiatric disorders.
Funding to New Jersey startups, for instance, is already up 37% year over year, thanks mostly to AI cloud infrastructure company CoreWeave , which raised a $1.1 While the Boston startup scene is famous for biotech and deeptech talent, the city has lagged other hubs in creation of ultra-high-valuation AI unicorns.
Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificial intelligence to biotech to energy. That deal followed Amazons 2023 announcement to invest up to $4 billion in Anthropic a deal that gave the Seattle-based e-commerce and cloud titan a minority stake in the startup. billion valuation.
The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.
Last fall Amazon agreed to invest up to $4 billion in Anthropic — giving the Seattle-based e-commerce and cloud titan a minority stake in Anthropic. That deal included Anthropic naming Amazon Web Services its primary cloud provider, as well as using AWS Trainium and Inferentia chips to build, train and deploy its models.
CoreWeave : AI cloud platform CoreWeave was super busy last year. Snyk : While many are waiting for cloud security startup Wiz to go public after its big $1 billion raise at a $12 billion valuation last year , we are going to look at another cyber firm with Israeli roots. In May, it raised a whopping $1.1 Companies House.
Large early-stage rounds went to data centers, renewable energy, AI, robotics and biotech. Large fundings were raised in multiple sectors such as AI, applied AI, energy, semiconductor, banking, security and aerospace, among others. Early stage flat Early-stage funding was flat in Q4. Seed settled Seed funding trailed in Q4, for now.
Last fall, Amazon agreed to invest up to $4 billion in Anthropic — giving the Seattle-based e-commerce and cloud titan a minority stake in the company. That deal included Anthropic naming Amazon Web Services its primary cloud provider, as well as using AWS Trainium and Inferentia chips to build, train and deploy its models.
Founded in 2021 by former SpaceX Hyperloop engineers Sharma and Derek Lukacs (who serves as CTO), RedBrick AI offers specialized annotation tools that can be accessed through a web browser and integrated within customers’ existing data storage system, such as AWS, Google Cloud Platform and Azure.
The deal comes just about a week after Google parent Alphabet announced its intention to buy cloud security unicorn Wiz for $32 billion the biggest ever M&A exit for a VC-backed company. The company has approximately 500 employees, with more than 200 in product development and engineering, and over 450 customers.
AmplifyBio , $50M, biotech: Ohio-based drug development company AmplifyBio received a $50 million investment — with ability to scale to $65 million — from Vitrian for its new manufacturing enablement center in New Albany, Ohio. based CrytocoinMiner , a cryptocurrency cloud-mining platform, raised a $100 million venture round.
Cloud is the big buzzword these days, with people talking about why it’s a smart move for companies , and lots of venture-backed startups developing easy ways for companies to make the shift. The firm is led by Andy Price, general partner, and also founder of cloud-focused executive search firm Artisanal Talent.
HealthAtom is aiming to be the go-to cloud-based operations system for small and midsize healthcare companies across Latin America (LatAm). After a consultation, a plan will be established and information can be transferred to the cloud platform, adhering to local regulations.
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
AI cloud infrastructure startup CoreWeave locked up a $1.1 Cloud security startup Wiz locked up the biggest cybersecurity round of the year thus far as it raised $1 billion at a $12 billion valuation. In April, it acquired New York-based cloud detection and response startup Gem Security. billion so far.
Once again, biotech made up nearly a third of the list while some other sectors that don’t usually make the list — developer platform and analytics — were represented. Uniquity Bio , $300M, biotech: It has become pretty much the norm to start off these lists with a big biotech raise. billion valuation led by GGV Capital.
This was a massive round for vertical SaaS, and the largest ever for a legal cloud technology company. Healthcare and AI lead The leading sector for investment was healthcare and biotech companies which raised $6 billion. Biotech and healthcare companies have dominated billion-dollar exits this year. The company raised $4.4
But they did say that like many companies in biotech they are doing what they can to support COVID-related therapies. The team can’t share any of their customers’ successes (though presumably there have been some) because of course all this work is highly confidential. and Western Europe (they’re based in Poland).
Kailera Therapeutics , $400M, biotech: Biotech was even bigger this week than normal. The Boston-based biotech announced its launch this week with a $400 million Series A financing co-led by Atlas Venture , Bain Capital Life Sciences and RTW Investments. Poolside has raised $626 million since being founded in May 2023.
Wiz , $1B, cybersecurity: Cloud security startup Wiz locked up the biggest cybersecurity round of the year thus far as it raised $1 billion at a $12 billion valuation. Just last month it acquired New York-based cloud detection and response startup Gem Security. The company says the new cash infusion could be used for more deal-making.
However, it wasn’t just AI that got funding in September, as biotech makes up about half the list. Candid Therapeutics , $370M, biotech: The biggest biotech raise of the month went to Candid Therapeutics. Arsenal Biosciences , $325M, biotech: South San Francisco-based Arsenal Biosciences had the next biggest biotech raise.
Two of its latest devices include the WISE-6610, a gateway for connecting up to 500 sensors and sending their data to cloud platforms using 3G/LTE or wired Ethernet connections. Tokuyu Biotech creates smart massage chairs and health care-related products that are connected to apps and sensor technologies. Systems & Technology Corp.
Mirador Therapeutics , $400M, biotech: More big biotech raises this week. Capstan Therapeutics , $175M, biotech: Capstan Therapeutics raised a $175 million Series B led by RA Capital Management. Clasp Therapeutics , $150M, biotech: Clasp Therapeutics is the next biotech to raise huge. billion, per Crunchbase.
That’s when Union’s team saw an opportunity to layer paid services on top of the project in the cloud. “A managed version of Flyte, called Union Cloud, will allow smaller teams and organizations to use the power of Flyte without the need to staff up on infrastructure teams,” Umare continued. Cloud advantage.
Halda Therapeutics , $126M, biotech: The big biotech round of the week came from New Haven, Connecticut-based Halda Therapeutics, a biotech startup developing therapies for prostate cancer and breast cancer, which raised a $126 million Series B extension from investors including Deep Track Capital and RA Capital Management.
Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. The company offers cloud computing services and hardware for training artificial intelligence software. Freenome , $254M, biotech: This is just the first of many big biotech raises this week. billion valuation.
Valuable clouds : Kyle reports how cloud security startup Wiz, now valued at $10 billion, raises $300 million. Raising more : Biotech proved a surprisingly bright spot in 2022’s startup correction , by Becca. Evernote layoffs : Bending Spoons recently acquired Evernote, and now it lays off 129 Evernote staffers , Kyle reports.
Healthcare/biotech companies took the lead with three companies that joined the board from this sector. Healthcare and biotech Element Biosciences , a DNA sequencing biotech company enabling genetic analysis, raised a $277 million Series D led by Wellington Management. Who invested?
The largest round went to CoreWeave , an AI cloud infrastructure startup that raised $1.1 Two others raised billion-dollar rounds: Scale AI , a data labeling and evaluation startup, and Wiz , a cloud cybersecurity provider. billion in a May Series C led by Coatue. billion upfront and up to $1.7 billion in milestone-based payments.
Other leading sectors include healthcare and biotech companies, which raised $5.1 As of the end of May, AI, healthcare and biotech are the leading sectors so far this year, with each raising around $27 billion in funding. Three were biotech companies EyeBiotech , HI-Bio and Mariana Oncology. billion last month.
Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. EvolutionaryScale , $142M, biotech: It was a big week for biotech. billion, per Crunchbase.
We are headquartered outside of Boston in the Biotech Startup hot spot. Since Cloud Software as a Service solutions first became available around 2015, we have been standing up Oracle Cloud based manufacturing solutions for a boat load of … Continue reading "Biotech Manufacturing Software – There’s a shift in the wind!".
Mavenir builds cloud-native software that allows enterprises and service providers to manage complex networks without relying on older telecom hardware such as routers and switches. This allows customers to scale operations more quickly on the cloud and without the expense of equipment.
based corporate ventures — including massive bets in AI, healthcare and the cloud. Salesforce ’s venture arm led a $106 million round for Menlo Park, California-based Together AI — which has developed a cloud platform to allow developers to build on open and custom AI models — at a $1.25 billion valuation in March.
We are headquartered outside of Boston in the Biotech Startup hot spot. Since Cloud Software as a Service solutions first became available around 2015, we have been standing up Oracle Cloud based manufacturing solutions for a boat load of Biotech start-ups. We’ve seen it really start to take off.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content